{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:13:45Z","timestamp":1791904425703,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-19206"],"award-info":[{"award-number":["IG-19206"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1245\/s10434-021-09587-7","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T19:07:20Z","timestamp":1614452840000},"page":"2899-2908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of Previous Gynecologic Surgical Procedures on Outcomes of Non-Gynecologic Peritoneal Malignancies Mimicking Ovarian Cancer: Less Is More?"],"prefix":"10.1245","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-9810","authenticated-orcid":false,"given":"Marcello","family":"Guaglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Baratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kusamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur C. V.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Montenovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"9587_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.amjsurg.2010.04.010","volume":"201","author":"PH Sugarbaker","year":"2011","unstructured":"Sugarbaker PH. Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives? Am J Surg. 2011;201:157\u20139.","journal-title":"Am J Surg."},{"key":"9587_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.critrevonc.2016.01.017","volume":"100","author":"D Baratti","year":"2016","unstructured":"Baratti D, Kusamura S, Pietrantonio F, Guaglio M, Niger M, Deraco M. Progress in treatments for colorectal cancer peritoneal metastases during the years 2010\u20132015: a systematic review. Crit Rev Oncol Hematol. 2016;100:209\u201322.","journal-title":"Crit Rev Oncol Hematol."},{"key":"9587_CR3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/jso.21787","volume":"103","author":"D Baratti","year":"2011","unstructured":"Baratti D, Kusamura S, Deraco M. Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research. J Surg Oncol. 2011;103:822\u201331.","journal-title":"J Surg Oncol."},{"key":"9587_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29\u201342.","journal-title":"Ann Surg."},{"issue":"11","key":"9587_CR5","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.ejso.2019.06.021","volume":"45","author":"M Deraco","year":"2019","unstructured":"Deraco M, Sinukumar S, Salcedo-Hern\u00e1ndez RA, Rajendra VJ, Baratti D, Guaglio M, et al. Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy: largest single-institute experience. Eur J Surg Oncol. 2019;45(11):2103\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"9587_CR6","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u201356.","journal-title":"J Clin Oncol."},{"key":"9587_CR7","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol."},{"key":"9587_CR8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575\u201381.","journal-title":"Ann Surg Oncol."},{"key":"9587_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jso.20676","volume":"95","author":"PH Sugarbaker","year":"2007","unstructured":"Sugarbaker PH. Peritoneum as the first-line of defense in carcinomatosis. J Surg Oncol. 2007;95:93\u20136.","journal-title":"J Surg Oncol."},{"issue":"Suppl 2","key":"9587_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ijgo.12614","volume":"143","author":"JS Berek","year":"2018","unstructured":"Berek JS, Kehoe ST, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2018;143(Suppl 2):59\u201378.","journal-title":"Int J Gynaecol Obstet."},{"key":"9587_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/cncr.20836","volume":"103","author":"TD Yan","year":"2005","unstructured":"Yan TD, Haveric N, Carmignani CP, Chang D, Sugarbaker PH. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer. 2005;103:839\u201349.","journal-title":"Cancer."},{"key":"9587_CR12","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/DCR.0000000000001156","volume":"61","author":"D Baratti","year":"2018","unstructured":"Baratti D, Kusamura S, Iusco D, Cotsoglou C, Guaglio M, Battaglia L, et al. Should a history of extraperitoneal disease be a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer peritoneal metastases? Dis Colon Rectum. 2018;61:1026\u201334.","journal-title":"Dis Colon Rectum."},{"key":"9587_CR13","first-page":"49","volume":"15","author":"P Jaquet","year":"1996","unstructured":"Jaquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49\u201358.","journal-title":"J Exp Clin Cancer Res."},{"key":"9587_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jso.21388","volume":"100","author":"M Deraco","year":"2009","unstructured":"Deraco M, Baratti D, Kusamura S, Laterza B, Balestra MR. Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol. 2009;100:321\u20138.","journal-title":"J Surg Oncol."},{"key":"9587_CR15","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Published: May 28, 2009 (v4.03: June 14, 2010) U.S.DEPARTMENT OF HEALTH AND HUMAN SERVICES."},{"key":"9587_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/0021-9681(78)90043-7","volume":"31","author":"KJ Rothman","year":"1978","unstructured":"Rothman KJ. Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chron Dis. 1978;31:557\u201360.","journal-title":"J Chron Dis."},{"key":"9587_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000217748","volume":"13","author":"CA Yedema","year":"1992","unstructured":"Yedema CA, Kenemans P, Wobbes T, Thomas CM, Bon GG, Mulder C, et al. Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas. Tumour Biol. 1992;13:18\u201326.","journal-title":"Tumour Biol."},{"key":"9587_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejso.2010.03.005","volume":"36","author":"D Baratti","year":"2010","unstructured":"Baratti D, Scivales A, Balestra MR, et al. Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol. 2010;36:463\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"9587_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SLA.0b013e31825704e3","volume":"256","author":"D Baratti","year":"2012","unstructured":"Baratti D, Kusamura S, Mingrone E, et al. Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2012;256:334\u201341.","journal-title":"Ann Surg."},{"key":"9587_CR20","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","volume":"249","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009;249:900\u20137.","journal-title":"Ann Surg."},{"key":"9587_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/uog.19174","volume":"53","author":"F Moro","year":"2019","unstructured":"Moro F, Pasciuto T, Djokovic D, Di Legge A, Granato V, Moruzzi MC, et al. Role of CA125\/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses. Ultrasound Obstet Gynecol. 2019;53:116\u201323.","journal-title":"Ultrasound Obstet Gynecol."},{"key":"9587_CR22","first-page":"A433","volume":"58","author":"SS S\u00f8rensen","year":"2011","unstructured":"S\u00f8rensen SS, Mosgaard BJ. Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis. Dan Med Bull. 2011;58:A433.","journal-title":"Dan Med Bull."},{"key":"9587_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1515\/med-2017-0020","volume":"12","author":"J Guo","year":"2017","unstructured":"Guo J, Yu J, Song X, Mi H. Serum CA125, CA199, and CEA combined detection for epithelial ovarian cancer diagnosis: a meta-analysis. Open Med Wars. 2017;12:131\u201337.","journal-title":"Open Med Wars."},{"key":"9587_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ejso.2018.02.010","volume":"44","author":"F Bruno","year":"2018","unstructured":"Bruno F, Baratti D, Martinetti A, Morelli D, Sottotetti E, Bonini C, et al. Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: a preliminary study. Eur J Surg Oncol. 2018;44:792\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"9587_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","volume":"6","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727\u201331.","journal-title":"Ann Surg Oncol."},{"key":"9587_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/DCR.0000000000001003","volume":"61","author":"P Bikram","year":"2018","unstructured":"Bikram P, Chukwuemeka I, Paul BK, Ihemelandu C, Sugarbaker PH. Prior surgical score: an analysis of the prognostic significance of an initial nondefinitive surgical intervention in patients with peritoneal carcinomatosis of a colorectal origin undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy. Dis Colon Rectum. 2018;61:347\u201354.","journal-title":"Dis Colon Rectum."},{"key":"9587_CR27","doi-asserted-by":"crossref","unstructured":"Chua TC, Liauw W, Zhao J, Morris DL. Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate. Ann Surg. 2011;253(4):769-73.","DOI":"10.1097\/SLA.0b013e31820b4dba"},{"key":"9587_CR28","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.ejso.2013.06.002","volume":"39","author":"HJ Braam","year":"2013","unstructured":"Braam HJ, Boerma D, Wiezer MJ, van Ramshorst B. Hyperthermic intraperitoneal chemotherapy during primary tumour resection limits extent of bowel resection compared to two-stage treatment. Eur J Surg Oncol. 2013;39:988\u201393.","journal-title":"Eur J Surg Oncol."},{"key":"9587_CR29","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.ejso.2019.08.004","volume":"45","author":"W Zhang","year":"2019","unstructured":"Zhang W, Tan C, Xu M, Wu X. Appendiceal mucinous neoplasm mimics ovarian tumors: challenges for preoperative and intraoperative diagnosis and clinical implication. Eur J Surg Oncol. 2019;45:2120\u20135.","journal-title":"Eur J Surg Oncol."},{"key":"9587_CR30","first-page":"335","volume":"100","author":"A Nissan","year":"2009","unstructured":"Nissan A, Stojadinovic A, Garofalo A, Esquivel J, Piso P. Evidence-based medicine in the treatment of peritoneal carcinomatosis: past, present, and future J Surg Oncol. 2009;100:335\u201344.","journal-title":"Evidence-based medicine in the treatment of peritoneal carcinomatosis: past, present, and future J Surg Oncol."},{"key":"9587_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","volume":"18","author":"MT Goodman","year":"2009","unstructured":"Goodman MT, Shvetsov YB. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995\u20132004. Cancer Epidemiol Biomarkers Prev. 2009;18:132\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"9587_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1525-1438.2001.01027.x","volume":"11","author":"R Halperin","year":"2001","unstructured":"Halperin R, Zehavi S, Langer R, Hadas E, Bukovsky I, Schneider D. Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. Int J Gynecol Cancer. 2001;11:403\u20138.","journal-title":"Int J Gynecol Cancer."},{"key":"9587_CR33","doi-asserted-by":"crossref","unstructured":"Patrick-Brown TDJH, Carr NJ, Swanson DM, Larsen S, Mohamed F, Flatmark K. Estimating the prevalence of pseudomyxoma peritonei in europe using a novel statistical method. Ann Surg Oncol. 2021;28(1):252\u20137.","DOI":"10.1245\/s10434-020-08655-8"},{"key":"9587_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/annonc\/mdl345","volume":"18","author":"P Boffetta","year":"2007","unstructured":"Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18:985\u201390.","journal-title":"Ann Oncol."},{"key":"9587_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1172-3-34","volume":"3","author":"AJ Moore","year":"2008","unstructured":"Moore AJ, Parker RJ, Wiggins J. Malignant mesothelioma. Orphanet J Rare Dis. 2008;3:34.","journal-title":"Orphanet J Rare Dis."},{"key":"9587_CR36","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10552-009-9328-9","volume":"20","author":"S Moolgavkar","year":"2009","unstructured":"Moolgavkar S, Meza R, Turim J. Pleural and peritoneal mesotheliomas in seer: age effects and temporal trends, 1973\u20132005. Cancer Causes Control. 2009;20:935\u201344.","journal-title":"Cancer Causes Control."},{"key":"9587_CR37","doi-asserted-by":"publisher","first-page":"680126","DOI":"10.1155\/2014\/680126","volume":"2014","author":"CK Lettieri","year":"2014","unstructured":"Lettieri CK, Garcia-Filion P, Hingorani P. Incidence and outcomes of desmoplastic small round cell tumor: results from the surveillance, epidemiology, and end results database. J Cancer Epidemiol. 2014;2014:680126.","journal-title":"J Cancer Epidemiol."},{"key":"9587_CR38","volume-title":"Global and Regional Estimates of the Incidence and Mortality for 38 Cancers: GLOBOCAN 2018","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al. Global and Regional Estimates of the Incidence and Mortality for 38 Cancers: GLOBOCAN 2018. International Agency for Research on Cancer\/World Health Organization, Lyon, 2018."},{"key":"9587_CR39","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival, and risk factors. Int J Cancer. 2014;134:622\u20138.","journal-title":"Int J Cancer."},{"key":"9587_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12885-015-1081-8","volume":"15","author":"F Seyfried","year":"2015","unstructured":"Seyfried F, von Rahden BH, Miras A, Gasser M, Maeder U, Kunzmann V, et al. Incidence, time course, and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin: a longitudinal experience from a prospectively collected database of 1108 patients. BMC Cancer. 2015;15:73.","journal-title":"BMC Cancer."},{"key":"9587_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/MPA.0b013e31825abf8c","volume":"42","author":"I Thomassen","year":"2013","unstructured":"Thomassen I, Lemmens VE, Nienhuijs SW, Luyer MD, Klaver YL, de Hingh IH. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study. Pancreas. 2013;42:72\u20135.","journal-title":"Pancreas."},{"key":"9587_CR42","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/DCR.0000000000000412","volume":"58","author":"P Quere","year":"2015","unstructured":"Quere P, Facy O, Manfredi S, Jooste V, Faivre J, Lepage C, Bouvier AM. Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study. Dis Colon Rectum. 2015;58:743\u201352.","journal-title":"Dis Colon Rectum."},{"key":"9587_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68:284\u201396.","journal-title":"CA Cancer J Clin."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09587-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-09587-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09587-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T17:31:28Z","timestamp":1618335088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-09587-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["9587"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-09587-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"11 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}